#Charlson
This opens in November and I'm so excited to see it! Early reviews say Andrew Scott is tremendous as the late actor Ian Charlson, who died of AIDS in 1990 after performing the title role in a National Theatre production of Hamlet.

youtu.be/L77dFMPjZg8?...
Elsinore - Official Trailer (2026) - Johnny Flynn, Andrew Scott, Olivia Colman
YouTube video by Regal
youtu.be
September 28, 2026 at 6:22 PM
Indices built to predict death explain little of what patients cost. Cost prediction needs a cost-based comorbidity index. https://www.mattheneus.com/editorial/cost-based-comorbidity-index-rxrisk-charlson-elixhauser-cost-prediction-2026-09-25 #HTA #HealthEconomics #RWE
September 25, 2026 at 12:00 PM
”Agent Charlson, press the X button to activate your Police Sense” and it just highlights all nearby minority people
September 22, 2026 at 2:21 PM
Intl study: Higher age-adjusted Charlson Comorbidity Index➡️↑mortality in carbapenem-resistant infections, esp. respiratory. Key factors: cirrhosis, diabetes, vascular disease.
Comorbidities and Patient Outcomes in Carbapenem-Resistant Gram-negative Bacterial Infections
AbstractIn an international cohort of hospitalized patients included in the Multi-Drug-Resistant Organism Network with carbapenem-resistant Gram-negative infections, increased age-adjusted Charlson Comorbidity Index scores were associated with increased mortality particularly in those with respiratory and less so in those with bloodstream infections. Cirrhosis, diabetes, and peripheral vascular disease were important contributors.
academic.oup.com
September 15, 2026 at 10:30 PM
See nitrogen research at Husker Harvest Days

Dirk Charlson, Nebraska digital agriculture educator, hopes this demonstration will show how digital tools can help farmers make better man...

www.farmprogress.com/husker...

Via: Antonie.ai
#SoilHealth #Agriculture #Crops #Monitoring #Analyses
September 10, 2026 at 1:55 PM
🚨 Severe Thunderstorm Warning issued September 6 at 5:23PM CDT until September 6 at 6:15PM CDT by NWS Bismarck ND 🚨
Additional Details Here.
September 6, 2026 at 10:30 PM
Congratulations to Digital Production & Electronic Technology Manager Garo Papazian on being recognized with Perkins' Janet and William James Excellence Award! 👏

Thanks to Garo, our digital audiobook operations are timely and efficient and our virtual programs run smoothly!
September 4, 2026 at 12:40 PM
New JMIR MedInform: Developing Country-Specific Charlson Comorbidity Index Mappings for Use With German Administrative Data: Methodological Comparative Study
Developing Country-Specific Charlson Comorbidity Index Mappings for Use With German Administrative Data: Methodological Comparative Study
Background: The Charlson Comorbidity Index (CCI) is widely used to quantify comorbidity burden in observational #research. Applying it to real-world data requires accurate International Classification of Diseases–based mappings. The commonly used mapping does not reflect current German coding standards. Objective: This study aimed to develop year-specific mappings (2004 to 2026) based on the German modification of the International Classification of Diseases, 10th Revision (ICD-10-GM), for the CCI with an open-source implementation and compare them with the commonly used mapping. Methods: For each year, mappings were curated via independent dual review with consensus. In 515,827 in#patient cases from a German tertiary center (2010-2024), year-appropriate mappings and the commonly used mapping were applied, and the results were pooled into 2 corresponding datasets that were subsequently compared. Agreement was assessed using the intraclass correlation coefficient (2-way mixed-effects model for absolute agreement based on single measurement), and the significance of the discordances was measured using the McNemar test. Results: Agreement was very high; 3.1% (16,136/515,827) of cases differed. A single code was present in 48.9% (7896/16,136) of the discordant cases and was intentionally excluded in the new mappings as it was not diagnostic for the category it was assigned to. Discordant results were found in 58.8% (10/17) of the categories (“peripheral vascular disease,” “mild liver disease,” and “severe liver disease”) being present in, respectively, 51.7% (8339/16,136), 17.4% (2813/16,136), and 16.4% (2657/16,136) of the discordant cases. After filtering the dataset to only include observations with any diagnosis of a malignant disease, 6.9% (9377/136,607) of cases differed, and 79.3% (7434/9377) of those differences were caused by the “peripheral vascular disease” category, suggesting significant discrepancies for specific #research questions. Conclusions: We provide transparent, year-specific ICD-10-GM (2004-2026) mappings and an open-source tool for CCI calculation. The mappings align with current German coding practice and enable reproducible, year-appropriate comorbidity adjustment using administrative data.
dlvr.it
September 3, 2026 at 8:35 PM
Took me a while to get the important message of this paper
journals.sagepub.com/doi/10.1177/...
#SorrySlow 😅

#Epidemiology #LongTermConditions #LTC

The team assumes that their register offers a TRUE estimate of the prevalence of #multimorbidity...
The role of primary care data in multimorbidity estimates using administrative health data - Clare Tazzeo, Katharina Schmidt-Mende, Karin Modig, 2026
Background This study aims to investigate the extent to which two frequently used multimorbidity measures, the Charlson Comorbidity Index (CCI) and the 2+ count...
journals.sagepub.com
September 2, 2026 at 11:57 AM
Two ocean scientists turned a pandemic-era gin hobby into Fathom Spirits, a Watsonville craft distillery making small-batch gins infused with Santa Cruz-inspired botanicals. Founders Elisha Wood-Charlson and Chad Kecy plan to open in September.
Science, the sea and gin: Meet Fathom Spirits, Watsonville’s newest distillery
Two ocean scientists turned a pandemic-era gin hobby into Fathom Spirits, a Watsonville craft distillery making small-batch gins infused with Santa Cruz-inspired botanicals. Founders Elisha…
lookout.co
August 27, 2026 at 2:00 PM
I see I see
August 11, 2026 at 12:30 AM
403 adults w/ BSI: 20.6% died😢. K. pneumoniae had higher mortality (26.8%) vs E. coli (17.4%). K. pneumoniae aHR 1.72; Charlson≥6 aHR 8.43; ESBL not predictive.
Klebsiella pneumoniae is associated with increased mortality versus Escherichia coli in carbapenem-susceptible Enterobacterales bacteraemia: a Peruvian cohort
AbstractObjectivesTo identify predictors of all-cause 30-day mortality in bloodstream infections (BSI) caused by carbapenem-susceptible Escherichia coli and Klebsiella pneumoniae, with emphasis on bacterial species and the extended-spectrum β-lactamase (ESBL) phenotype.MethodsThis was a single-centre retrospective cohort study of adults with a first episode of BSI due to carbapenem-susceptible E. coli or K. pneumoniae at a referral hospital in Lima, Peru (June 2020–December 2023). Primary outcome: All-cause 30-day mortality. A multivariable Cox model was built, with covariate selection guided by a directed acyclic graph, and the species × ESBL interaction was tested.ResultsOf the 403 patients (median age 66 years, 55.8% men; 58.6% ESBL+), 83 (20.6%) died. Mortality was higher in patients with K. pneumoniae than in those with E. coli (26.8% versus 17.4%; log-rank P = 0.018). In the multivariable analysis, K. pneumoniae was an independent predictor [adjusted HR (aHR) 1.72; 95% CI, 1.09–2.73; P = 0.021], as was a Charlson score ≥6 (aHR 8.43; 95% CI, 3.33–21.3; P < 0.001). ESBL was not an independent predictor (aHR 1.45; 95% CI, 0.92–2.29; P = 0.113), nor was the species × ESBL interaction (P = 0.43). The effect of K. pneumoniae was consistent across all sensitivity analyses (aHR 1.66–1.94).ConclusionsK. pneumoniae nearly doubled mortality compared with E. coli, independently of ESBL, which did not predict mortality in this cohort of carbapenem-susceptible isolates. These findings challenge the assumption of prognostic homogeneity within carbapenem-susceptible Enterobacterales and support species stratification.
academic.oup.com
August 10, 2026 at 12:00 PM
Trenton Charlson (he/him) has been creating crosswords in 2016. His first was published in the New York Times in 2017. On a cruise in 2016, he was a contestant on a Who Wants to be a Millionaire style game show; he answered all of the questions correctly to win the grand prize, a backpack.
August 7, 2026 at 1:02 PM
Lolla lineup! Main tournament slate: Trenton Charlson, Carina da Rosa, Will Nediger, Ada Nicolle, Adam Wagner, Amie Walker. Tiebreaker: Laura Braunstein. Bonus meta suites: Doug Peterson, Scott Weiss. bemoresmarter.com/lpz
August 6, 2026 at 1:53 PM
Take a leisurely walk alongside the sandy beaches and blue waves of #CapeCod in our latest narrated #Soundscape episode! 🐚

Your narrators are our very own Perkins Library Director Kim Charlson and Children’s and Young Adult Services Librarian Andrea Everett!

Listen now: https://bit.ly/3TqQA58
August 3, 2026 at 5:15 PM
Freddy may not be the best student, but who cares? It's the final day of school! He's excited to finally get it over with. Then he's excited to finally get over with again. And again. And again...

Charlson captures an elementary school kid's worst nightmare: never graduating from fifth grade!
July 31, 2026 at 5:47 PM
📢New article alert

Mortality risk estimation for autistic older adults: comparing novel machine-learning derived weights vs standard weights for the Charlson Comorbidity Index

🔗 becarispublishing.com/doi/10.57264...

#OpenAccess #JCER #Autism #MachineLearning #RealWorldEvidence #HealthOutcomes
Mortality risk estimation for autistic older adults: comparing novel machine-learning derived weights versus standard weights for the Charlson Comorbidity Index
Aim: We aimed to compare Quan and colleagues (2011) established weights for the Charlson Comorbidity Index (CCI) conditions to autism-specific weights for predicting mortality risk in autistic older a...
becarispublishing.com
July 30, 2026 at 9:31 AM
261 Campylobacter BSI cases: 34.1% IC, 65.9% ID; 75% fluoroquinolone resistance. 8% relapse, mainly humoral-ID (18.3%). 30-day death: 9.9% total, lower in humoral-ID (4.8%) vs IC (13.5%).⚠️
Campylobacter spp Bloodstream Infections in Immunocompetent vs Immunodeficient Patients: A Multinational Cohort Study (2009–2024)
Campylobacter spp bloodstream infections (BSIs) are an emerging clinical challenge, yet information on their clinical features remains limited. We aimed to evaluate their differential clinical characteristics and outcomes in immunocompetent (IC) and immunodeficient (ID) patients.MethodsA multicenter, multinational, retrospective cohort study of consecutive Campylobacter spp BSIs between 2009 and 2024 was carried out. Demographics, Charlson comorbidity index, types of immunodeficiencies, clinical characteristics, and antimicrobial susceptibility were analyzed. The primary outcomes were relapse or reinfection and death (all-cause mortality outcome).ResultsA total of 261 episodes were included, 89 (34.1%) in IC and 172 (65.9%) in ID patients. Among the 172 ID patients, 104 (60.5%) and 68 (39.5%) had humoral or nonhumoral immunodeficiency (primary or secondary), and 42 (24.4%) had primary immunodeficiencies (PIDs). Patients with humoral immunodeficiency (humoral-ID patients) were younger (median age, 40 years [interquartile range, 23–66 years]), had lower Charlson comorbidity indexes (2 [1–5]), and had a higher frequency of previous Campylobacter spp infection. Resistance rates to fluoroquinolones (75%) and macrolides (14.5%) were high. BSI relapse or reinfection occurred in 21 (8.0%) patients, mostly humoral-ID patients (n = 19 [18.3%]), 11 (57.9%) of whom had PID. Death occurred with 30 days (all-cause mortality outcome) in 26 patients (9.9%) across the entire cohort; the 30-day mortality rate was lower in humoral-ID (n = 5 [4.8%]) than in IC (n = 12 [13.5%]; P = .05) patients.ConclusionsHumoral-ID patients and those with Campylobacter spp BSI were younger and had fewer comorbid conditions, and Campylobacter coli was the most frequent species. Relapse or reinfection was common in humoral-ID patients, particularly those with PID. The antimicrobial resistance in C coli and Campylobacter jejuni represents a clinical concern.
academic.oup.com
July 23, 2026 at 3:30 AM
medicalcoder 0.9.0 is now on CRAN

What’s new: Charlson methods, ICD-10-AM, ICD-10-SE

Why use it: self-contained, longitudinally aware, auditable mappings

#rstats #HealthInformatics #EHR #ClinicalResearch #RiskAdjustment #PublicHealth #comorbidity #Charlson #Elixhuaser #PCCC #pediatrics
July 16, 2026 at 2:46 PM